参考文献/References:
[1]ahmed km, li jj. atm-nf-kappab connection as a target for tumor radiosensitization[j]. curr cancer drug targets, 2007, 7(4):335-342.
[2]reya t, morrison sj, clarke mf, et al. stem cells, cancer, and cancer stem cells[j]. nature, 2001, 414(6859):105-111.
[3]bonnet d, dick je. human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[j]. nat med, 1997, 3(7):730-737.
[4]driessens g, beck b, caauwe a, et al. defining the mode of tumour growth by clonal analysis[j]. nature, 2012, 488(7412):527-530.
[5]jordan ct, guzman ml, noble m. cancer stem cells[j]. n engl j med, 2006, 355(12):1253-1261.
[6]ch′ang hj, maj jg, paris f, et al. atm regulates target switching to escalating doses of radiation in the intestines[j]. nat med, 2005, 11(5):484-490.
[7]bao s, wu Q, mclendon re, et al. glioma stem cells promote radioresistance by preferential activation of the dna damage response[j]. nature, 2006, 444(7120):756-760.
[8]shimura t, noma n, oikawa t, et al. activation of the akt/cyclin d1/cdk4 survival signaling pathway in radioresistant cancer stem cells[j/ol]. oncogenesis, 2012, 1(6):12[2015-08-30]. http://www. ncbi. nlm. nih. gov/pmc/articles/pmc3412645/pdf/oncsis201212a. pdf.
[9]diehn m, cho rw, clarke mf. therapeutic implications of the cancer stem cell hypothesis[j]. semin radiat oncol, 2009, 19(2):78-86.
[10]kim jj, tannock if. repopulation of cancer cells during therapy:an important cause of treatment failure[j]. nat rev cancer, 2005, 5(7):516-525.
[11]wang y, li w, patel ss, et al. blocking the formation of radiation-induced breast cancer stem cells[j]. oncotarget, 2014, 5(11):3743-3755.
[12]gebski v, lagleva m, keech a, et al. survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses:a clinical perspective[j]. j natl cancer inst, 2006, 98(1):26-38.
[13]gupta pb, chaffer cl, weinberg ra. cancer stem cells:mirage or reality?[j]. nat med, 2009, 15(9):1010-1012.
[14]yu vy, nguyen d, pajonk f, et al. incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance[j]. int j radiat oncol biol phys, 2015, 91(4):866-875.
[15]tothova z, gilliland dg. a radical bailout strategy for cancer stem cells[j]. cell stem cell, 2009, 4(3):196-197.
[16]diehn m, cho rw, lobo na, et al. association of reactive oxygen species levels and radioresistance in cancer stem cells[j]. nature, 2009, 458(7239):780-783.
[17]spitz dr, azzam ei, li jj, et al. metabolic oxidation/reduction reactions and cellular responses to ionizing radiation:a unifying concept in stress response biology[j]. cancer metastasis rev, 2004, 23(3/4):311-322.
[18]phillips tm, mcbride wh, pajonk f. the response of cd24(-/low)/cd44+ breast cancer-initiating cells to radiation[j]. j natl cancer inst, 2006, 98(24):1777-1785.
[19]l-hajj m, wicha ms, benito-hernandez a, et al. prospective identification of tumorigenic breast cancer cells[j]. proc natl acad sci u s a, 2003, 100(7):3983-3988.
[20]zhang m, atkinson rl, rosen jm. selective targeting of radiation-resistant tumor-initiating cells[j]. proc natl acad sci u s a, 2010, 107(8):3522-3527.
[21]cao n, li s, wang z, et al. nf-kappab-mediated her2 overexpression in radiation-adaptive resistance[j]. radiat res, 2009, 171(1):9-21.
[22]duru n, fan m, candas d, et al. her2-associated radioresistance of breast cancer stem cells isolated from her2-negative breast cancer cells[j]. clin cancer res, 2012, 18(24):6634-6647.
[23]huang ph, cavenee wk, furnari fb, et al. uncovering therapeutic targets for glioblastoma:a systems biology approach[j]. cell cycle, 2007, 6(22):2750-2754.
[24]kang mk, hur bi, ko mh, et al. potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma[j/ol]. bmc neurosci, 2008, 9:15[2015-08-30]. http://www. ncbi. nlm. nih. gov/pmc/articles/pmc2266936/pdf/1471-2202-9-15. pdf
[25]hemmati hd, nakano i, lazareff ja, et al. cancerous stem cells can arise from pediatric brain tumors[j]. proc natl acad sci u s a, 2003, 100(25):15178-15183.
[26]singh sk, clarke id, terasaki m, et al. identification of a cancer stem cell in human brain tumors[j]. neurosurgery, 2003, 53(2):487-488.
[27]singh sk, hawkins c, clarke id, et al. identification of human brain tumour initiating cells[j]. nature, 2004, 432(715):396-401.
[28]galli r, binda e, orfanelli u, et al. isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma[j]. cancer res, 2004, 64(19):7011-7021.
[29]lim yc, roberts tl, day bw, et al. a role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells[j]. mol cancer ther, 2012, 11(9):1863-1872.
[30]uchida n, buck dw, he d, et al. direct isolation of human central nervous system stem cells[j]. proc natl acad sci u s a, 2000, 97(26):14720-14725.
[31]tamura k, aoyagi m, ando n, et al. expansion of cd133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy[j]. j neurosurg, 2013, 119(5):1145-1155.
[32]cheng l, wu Q, huang z, et al. l1cam regulates dna damage checkpoint response of glioblastoma stem cells through nbs1[j]. embo j, 2011, 30(5):800-813.
[33]squatrito m, brennan cw, helmy k, et al. loss of atm/chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas[j]. cancer cell, 2010, 18(6):619-629.
[34]facchino s, abdouh m, chatoo w, et al. bmi1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the dna damage response machinery[j]. j neurosci, 2010, 30(30):10096-10111.
[35]gray gk, mcfarland bc, nozell se, et al. nf-κb and stat3 in glioblastoma:therapeutic targets coming of age[j]. expert rev neurother, 2014, 14(11):1293-1306.
[36]hambardzumyan d, becher oj, rosenblum mk, et al. pi3k pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo[j]. genes dev, 2008, 22(4):436-448.
[37]danial nn, korsmeyer sj. cell death:critical control points[j]. cell, 2004, 116(2):205-219.
[38]ahmed km, nantajit d, fan m, et al. coactivation of atm/erk/nf-kappab in the low-dose radiation-induced radioadaptive response in human skin keratinocytes[j]. free radic biol med, 2009, 46(11):1543-1550.
[39]bhat kp, balasubramaniyan v, vaillant b, et al. mesenchymal differentiation mediated by nf-κb promotes radiation resistance in glioblastoma[j]. cancer cell, 2013, 24(3):331-346.
[40]wiegman em, blaese ma, loeffler h, et al. tgfbeta-1 dependent fast stimulation of atm and p53 phosphorylation following exposure to ionizing radiation does not involve tgfbeta-receptor i signalling[j]. radiother oncol, 2007, 83(3):289-295.
[41]pellicciotta i, marciscano ae, hardee me, et al. development of a novel multiplexed assay for quantification of transforming growth factor-β(tgf-β)[j]. growth factors, 2015, 33(2):79-91.
[42]wang x, gao z, wu x, et al. inhibitory effect of tgf-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts[j/ol]. pharm biol, 2015:1-9[2015-08-30]. http://www. tandfonline. com/doi/pdf/10. 3109/13880209. 2015. 1059862.
[43]yu dk, lee b, kwon m, et al. phlorofucofuroeckol b suppresses inflammatory responses by down-regulating nuclear factor κb activation via akt, erk, and jnk in lps-stimulated microglial cells[j]. int immunopharmacol, 2015, 28(2):1068-1075.
[44]abel ev, kim ej, wu j, et al. the notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer[j/ol]. plos one, 2014, 9(3):91983[2015-08-30]. http://www. ncbi. nlm. nih. gov/pmc/articles/pmc3960140/pdf/pone. 0091983. pdf.
[45]wang j, wakeman tp, lathia jd, et al. notch promotes radioresistance of glioma stem cells[j]. stem cells, 2010, 28(1):17-28.
[46]palaga t, ratanabunyong s, pattarakankul t, et al. notch signaling regulates expression of mcl-1 and apoptosis in ppd-treated macrophages[j]. cell mol immunol, 2013, 10(5):444-452.
[47]griner em, kazanietz mg. protein kinase c and other diacylglycerol effectors in cancer[j]. nat rev cancer, 2007, 7(4):281-294.
[48]kim mj, kim rk, yoon ch, et al. importance of pkcδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment[j]. j cell sci, 2011, 124(pt 18):3084-3094.
[49]lomonaco sl, finniss s, xiang c, et al. the induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells[j]. int j cancer, 2009, 125(3):717-722.
相似文献/References:
[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[4]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[5]黄娟,颜剑豪,梁联保,等.注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响[J].国际放射医学核医学杂志,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
Huang Juan,Yan Jianhao,Liang Lianbao,et al.Evaluation of the diffusion-weighted imaging after contrast for the characterization of breast tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
[6]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[7]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[8]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[9]胡梦裳,章斌.PET/CT显像在乳腺癌疗效评价及预后中的作用[J].国际放射医学核医学杂志,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
Hu Meng-shang,Zhang Bin.The role of PET/CT imaging in the evaluation of the efficacy and prognosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
[10]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]